The industry has much to be optimistic about in 2016. But a look at the winner of our “Anti-Brand of the Year” clarifies how many outside the industry really see it.
... /Read more/
Payers, providers, patients and pharma companies all want to understand the value of specific treatments – and patient registries can help them do that. ... /Read more/
GDP is seeing ‘track and trace’ becoming indispensable for drug product integrity. Interactive Response Technologies may offer a potential solution. ... /Read more/